Abstract
Those cancers, like thyroid and pancreatic cancer, with the lowest 5-year mortality rates, have Replikin Counts of about 20; lung and brain cancers, with the highest 5-year mortality rates, have Replikin Counts of 275 and 325 respectively; the others fall in between with approximate linearity. This is the first quantitative relationship of a genomic structure, Replikins, to 5-year mortality rates.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bogoch, S., Bogoch, E. Genome Replikin Count Predicts Increased Lethality of Cancer. Nat Prec (2012). https://doi.org/10.1038/npre.2012.7143.1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/npre.2012.7143.1